Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma	Recruiting	Early phase 1	2026-04-01		NCT06435351

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
H. Lee Moffitt Cancer Center and Research Institute	162

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Moffitt Cancer Center	Tampa	United States	523

Clinical trials